Medinet Co
Leading CDMO in regenerative medicine and cell therapy, offering comprehensive solutions from research to commercial launch. Learn more
Launch date
Employees
Market cap
AUD144m
Enterprise valuation
AUD91m (Public information from Sep 2024)
Share price
JPY45 2370.T
Tokyo Japan (HQ)
Authorizing premium user...